摘要
目的:探讨哌立福辛对体外培养的人胃癌SGC7901细胞生长增殖的影响并探讨其机制。方法:分别用不同浓度的哌立福辛(0.125、0.250、0.500、0.750、1.500μmol/L)对SGC7901细胞进行干预后,采用磺酰罗丹明B(SRB)法检测细胞增殖变化;平板克隆实验检测细胞克隆形成能力;Real-time PCR、Western blot法检测癌症相关基因eIF4E及AEG-1 mRNA及蛋白表达。结果:哌立福辛呈时间及浓度依赖性抑制胃癌SGC7901细胞的增殖,并降低细胞的克隆形成能力;细胞内AKT信号通路中AEG-1、eIF4E的表达明显降低。结论:哌立福辛具有抑制胃癌SGC7901细胞增殖的作用;通过降低AKT信号通路中AEG-1和eIF4E的mRNA及蛋白表达可能是发挥增殖抑制作用的机制之一。
Objective:To investigate the effects of perifosine on the growth of human gastric carcinoma cell line SGC7901.Methods:The inhibitory effect of perifosine on the growth of human gastric cancer cell line SGC7901 was observed at different concentrations(0.125,0.250,0.500,0.750,1.500) μmol/L by sulforhodamine B(SRB)assay.Plate colony formation assay was performed to detect the colony formation rate.The expression levels of eIF4E and AEG-1 were determined by Real-time PCR and Western blot.Results:Perifosine inhibited the growth of gastric cancer cell line SGC7901 in dose-and time-dependent manners.The cell colony formation rate was statistically decreased(P 0.05) as compared with those in the control.The mRNA and protein levels of eIF4E and AEG-1 were reduced gradually dose-dependently.Conclusion:Perifosine,an AKT inhibitor,inhibits the growth and the colony formation rate of human gastric cancer cell via downregulating the expression of eIF4E and AEG-1.
出处
《南京医科大学学报(自然科学版)》
CAS
CSCD
北大核心
2013年第8期1077-1080,共4页
Journal of Nanjing Medical University(Natural Sciences)
基金
常州市卫生局重大项目(ZD200906)
关键词
哌立福辛
胃癌
增殖
抑制
perifosine
gastric carcinoma
proliferation
inhibition